Dr. Ankur Bahl is a highly recognized Senior Director of Medical Oncology at Fortis Hospital in Gurgaon.
He has an MBBS degree and further obtained his MD in Internal Medicine, and then completed his DM in Medical Oncology, which makes him a highly qualified professional in his field.
Dr.Bahl's training background is extensive and he was a student of the best medical institutions, where he was instilled with great knowledge and expertise in oncology.
During his long-term job, Dr Bahl has been a specialist in a variety of cancer treatments, especially those for solid tumours and haematological malignancies.
He is a recognised figure in the fields of chemotherapy, targeted therapy, and immunotherapy. Dr. Bahl's dedication to his profession is further demonstrated by his participation in various clinical trials and the continuing contributions he makes to oncology research, which have earned him a reputation for being a recognized and respected medical professional.
His approach involves the use of the most up-to-date treatment regimens, which are designed to address specific patient requirements and, therefore, offer holistic and empathetic care.
Ranked No. 2 in Delhi NCR’s Best Private Hospitals by The Week Magazine Survey, 2019 India's 1st robot-assisted Joint Replacement Surgery JCI & NABH Accredited Hospital.
Founded in 2013, Fortis Memorial Research Institute (FMRI) Hospital Gurgaon is a multi-super specialty hospital equipped with world-class infrastructure and highly qualified medical professionals, including super sub-specialists
Achieved rank 2 in a global study of ‘30 Most Technologically Advanced Hospitals in the World'
Top specialties of the hospital include cardiac sciences, gastroenterology and hepatobiliary sciences, hematology, nephrology, neurology, oncology
A flagship hospital of the extended Fortis network of hospitals, FMRI has set new benchmarks as a leading adopter of new technology and excellence in clinical care
At a national level, FMRI operates the second-largest program for bone marrow transplants, performing over 200 transplants in the last year
International patients comprise approximately 22 percent of the total patient volume, and can avail of dedicated features such as translators, prayer rooms, money exchange, and international patient lounges
Fortis Memorial Research Institute is accredited by the Joint Commission International (JCI), the National Accreditation Board for Hospitals & Healthcare Providers (NABH), and the National Accreditation Board for Testing and Calibration Laboratories (NABL)
